Transcriptomics

Dataset Information

0

Anabolic effects of salbutamol are lost upon removal of muscle contraction


ABSTRACT: Highlights: - Muscle disuse causes atrophy and insulin resistance; salbutamol counteracts both. - However, salbutamol’s effects are inhibited in immobilized human and mouse limbs. - RNA-seq reveals blunted signaling effects by salbutamol during immobilization. Abstract: Salbutamol’s efficacy depends on muscle contraction.Muscle disuse leads to rapid loss of muscle mass and development of insulin resistance, which may be ameliorated by beta2-agonist administration. Here, we tested the impact of the fast-acting beta2-agonist salbutamol during immobilization. In humans, salbutamol enhanced insulin-stimulated glucose disposal on the whole-body level, but not in immobilized muscle. Salbutamol decreased the efflux of amino acids from the immobilized forearm, indicating increased muscle protein synthesis and/or inhibition of breakdown, but did not affect amino acid net balance. In agreement, in mice salbutamol increased cumulative muscle protein synthesis, but did not result in a net gain of muscle mass upon immobilization, due to an accompanying increase in muscle protein turnover. Molecular analyses revealed immobilization inhibited salbutamol’s effects on muscle-transcriptome. In conclusion, salbutamol can increase muscle mass and glucose uptake, but not effectively in inactive muscle, demonstrating that the mechanism of action and efficacy of beta2-adrenoreceptor signaling is hampered without muscle contraction.

ORGANISM(S): Mus musculus

PROVIDER: GSE278016 | GEO | 2025/09/25

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2025-02-15 | GSE287100 | GEO
2023-12-06 | GSE237537 | GEO
2021-04-22 | GSE172501 | GEO
2022-09-28 | GSE185560 | GEO
2019-02-18 | GSE113165 | GEO
2022-12-16 | GSE213148 | GEO
2007-08-28 | E-GEOD-8872 | biostudies-arrayexpress
2023-12-12 | GSE216408 | GEO
2019-04-01 | GSE97312 | GEO
2022-09-27 | GSE211204 | GEO